Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Study reveals insights into feline chronic kidney disease
Researchers found differentially expressed proteins between cats with hypertensive CKD and cats with normotensive CKD.
Researchers have found potential biomarkers in feline urine.
 
A new study, published in the latest issue of the Journal of Small Animal Practice (JSAP), has successfully isolated extracellular vesicles from cat urine and discovered differentially expressed proteins between cats with normotensive chronic kidney disease (CKD) and hypertensive CKD. 

It is the first study to characterise the proteome of feline urinary extracellular vesicles that originate in the kidney and could be a source of biomarkers for disease progression and potential therapeutic targets.

Nicola Di Girolamo, the editor of JSAP, said in response to the study: “CKD is particularly common in geriatric cats and associated hypertension can contribute to morbidity, so the search for factors associated with disease is highly valuable.”

The researchers used three different methods (precipitation, precipitation followed by size exclusion chromatography, and ultrafiltration followed by exclusion chromatography) to isolate extracellular vesicles from stored urine samples from a sample of 28 cats. Nine cats were classed with normal renal function, 10 with normotensive CKD and nine with hypertensive CKD. 

Unexpectedly, the study found no differential protein expression between the extracellular vesicles of cats with normal renal function and those with either normotensive CKD or hypertensive CKD. This surprising result may have been due to the small category sizes used in the study.

However, the researchers did find a total of five differentially expressed proteins between cats with hypertensive CKD and cats with normotensive CKD. These included increased expression of aminopeptidase and decreased expression of alpha-2-macroglobulin, cauxin, inter-alpha-trypsin inhibitor heavy chain 4 and transferrin.

The authors of the study concluded that further investigation is warranted into the usefulness of these proteins as therapeutic targets or biomarkers.

The study, 'Urinary extracellular vesicles as a source of protein-based biomarkers in feline chronic kidney disease and hypertension', can be read online or in the January issue of JSAP. The research was funded by the BSAVA through its fundraising and grant-awarding arm, PetSavers.

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.